Academies Internship Information Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search



This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (51)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, M. D.
Right arrow Articles by Eaton, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott, M. D.
Right arrow Articles by Eaton, J. W.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

Proc. Natl. Acad. Sci. USA
Vol. 94, pp. 7566-7571, July 1997
Medical Sciences

Chemical camouflage of antigenic determinants: Stealth erythrocytes

Mark D. Scott*,, Kari L. Murad*, Fotios Koumpouras*, Margaret Talbot*, and John W. EatonDagger

* Division of Experimental Pathology, Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY 12208; and Dagger  Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030

Communicated by Helen M. Ranney, Alliance Pharmaceutical Corporation, San Diego, CA, May 5, 1997 (received for review December 13, 1996)

In a number of clinical circumstances it would be desirable to artificially conceal cellular antigenic determinants to permit survival of heterologous donor cells. A case in point is the problem encountered in transfusions of patients with rare blood types or chronically transfused patients who become allosensitized to minor blood group determinants. We have tested the possibility that chemical modification of the red blood cell (RBC) membrane might serve to occlude antigenic determinants, thereby minimizing transfusion reactions. To this end, we have covalently bound methoxy(polyethylene glycol) (mPEG) to the surface of mammalian RBC via cyanuric chloride coupling. Human RBC treated with this technique lose ABO blood group reactivity as assessed by solution-phase antisera agglutination. In accord with this, we also find a profound decrease in anti-blood group antibody binding. Furthermore, whereas human monocytes avidly phagocytose untreated sheep RBC, mPEG-derivatized sheep RBC are ineffectively phagocytosed. Surprisingly, human and mouse RBC appear unaffected by this covalent modification of the cell membrane. Thus, mPEG-treated RBC are morphologically normal, have normal osmotic fragility, and mPEG-derivatized murine RBC have normal in vivo survival, even following repeated infusions. Finally, in preliminary experiments, mPEG-modified sheep RBC intraperitoneally transfused into mice show significantly improved (up to 360-fold) survival when compared with untreated sheep RBC. We speculate that similar chemical camouflage of intact cells may have significant clinical applications in both transfusion (e.g., allosensitization and autoimmune hemolytic disease) and transplantation (e.g., endothelial cells and pancreatic beta  cells) medicine.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?


This article has been cited by other articles in HighWire Press-hosted journals:


Home page
 Exp. Biol. Med.Home page
E. Chambers and S. Mitragotri
Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation
Experimental Biology and Medicine, July 1, 2007; 232(7): 958 - 966.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
G. Garratty, M. J. Telen, and L. D. Petz
Red Cell Antigens as Functional Molecules and Obstacles to Transfusion
Hematology, January 1, 2002; 2002(1): 445 - 462.
[Abstract] [Full Text]

Home page
 BloodHome page
D. P. Blackall, J. K. Armstrong, H. J. Meiselman, and T. C. Fisher
Polyethylene glycol-coated red blood cells fail to bind glycophorin A-specific antibodies and are impervious to invasion by the Plasmodium falciparum malaria parasite
Blood, January 15, 2001; 97(2): 551 - 556.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. L. Murad, E. J. Gosselin, J. W. Eaton, and M. D. Scott
Stealth Cells: Prevention of Major Histocompatibility Complex Class II-Mediated T-Cell Activation by Cell Surface Modification
Blood, September 15, 1999; 94(6): 2135 - 2141.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. L. Murad, K. L. Mahany, C. Brugnara, F. A. Kuypers, J. W. Eaton, and M. D. Scott
Structural and Functional Consequences of Antigenic Modulation of Red Blood Cells With Methoxypoly(Ethylene Glycol)
Blood, March 15, 1999; 93(6): 2121 - 2127.
[Abstract] [Full Text] [PDF]